2024/03/27 更新

写真a

イケダ シュウタ
池田 脩太
IKEDA Shuta
所属
医学部附属病院 血管外科 助教
大学院担当
大学院医学系研究科
職名
助教

学位 1

  1. 医学博士 ( 2022年3月   名古屋大学 ) 

研究分野 1

  1. ライフサイエンス / 心臓血管外科学

 

論文 12

  1. <Editors' Choice> Thoracic endovascular aortic repair and spinal cord injury.

    Banno H, Lee C, Ikeda S, Kawai Y, Sugimoto M, Niimi K

    Nagoya journal of medical science   86 巻 ( 1 ) 頁: 16 - 23   2024年2月

     詳細を見る

    記述言語:英語  

    DOI: 10.18999/nagjms.86.1.16

    PubMed

  2. Predictors of infrapopliteal vein bypass graft revision in patients with chronic limb-threatening ischemia

    Kawai, Y; Kodama, A; Sato, T; Ikeda, S; Tsuruoka, T; Sugimoto, M; Niimi, K; Banno, H; Komori, K

    VASCULAR   32 巻 ( 1 ) 頁: 65 - 75   2024年2月

     詳細を見る

    記述言語:英語   出版者・発行元:Vascular  

    Purpose: Surgical revascularization is the standard treatment for chronic limb-threatening ischemia (CLTI). However, some patients may require reintervention. The Global Anatomic Staging System (GLASS), which evaluates the complexity of infrainguinal lesions, was proposed. This study aimed to identify predictors for graft revision and evaluate whether GLASS impacts vein graft revision. Methods: Between 2011 and 2018, CLTI patients who underwent de novo infrapopliteal bypass using autogenous veins were retrospectively analyzed. To assess anatomic complexity with GLASS, femoropopliteal, infrapopliteal, and inframalleolar/pedal (IM) disease grades were determined. The outcomes of patients with or without graft revision were compared. Cox regression analysis was performed. Results: Thirty-six of the 80 patients underwent reintervention for graft revision. Compared to the non–graft revision group, the graft revision group exhibited significantly higher rates of GLASS stage III (66% vs 81%, p = 0.046) and grade P2 IM disease (25% vs 58%, p = 0.009). Multivariate analysis revealed that IM grade P2 (hazard ratio [HR], 3.35; 95% confidence interval [CI], 1.66–6.75; p = 0.001) and spliced vein grafts (HR, 3.18; 95% CI, 1.43–7.06; p = 0.005) were significantly associated with graft revision. Conclusions: This study demonstrated that IM grade P2 and spliced vein grafts were predictors of graft revision. The GLASS stratification of IM disease grade may be useful in optimizing treatment for CLTI.

    DOI: 10.1177/17085381221124706

    Web of Science

    Scopus

    PubMed

  3. Optimal D-Dimer Cutoff Values for Diagnosing Deep Vein Thrombosis in Patients with Comorbid Malignancies

    Niimi, K; Nishida, K; Lee, C; Ikeda, S; Kawai, Y; Sugimoto, M; Banno, H

    ANNALS OF VASCULAR SURGERY   98 巻   頁: 293 - 300   2024年1月

     詳細を見る

    記述言語:英語   出版者・発行元:Annals of Vascular Surgery  

    Background: Patients with malignancy are at high risk of venous thromboembolism, and early diagnosis is important. The Khorana score is known as a risk assessment for cancer-related thrombosis during chemotherapy, but there are still few reports on its diagnostic potential, the optimal D-dimer cutoff values for indications other than chemotherapy and the use of the Khorana score in combination with D-dimers. In this study, we examined the clinical appropriateness of increasing the D-dimer cutoff value. Methods: We retrospectively studied 208 malignancies out of 556 patients who underwent lower extremity venous ultrasonography at our hospital over a 2-year period from January 2018 to December 2019. The optimal D-dimer cutoff value for predicting deep vein thrombosis (DVT) in patients with malignancy was calculated by the Youden index. The usefulness of the Khorana score alone and the model combining the Khorana score with D-dimer for predicting DVT diagnosis was compared using receiver operating characteristic analysis. Results: Of 208 eligible patients, 59 (28.4%) had confirmed DVT. The optimal D-dimer cutoff value for predicting DVT comorbidity in patients with malignancy was 3.96 μg/mL. When the new D-dimer cutoff value was set at 4.0 μg/mL, the odds ratio (OR) for DVT diagnosis was 4.23 (95% confidence interval (CI) 2.10–8.55, P < 0.001), which was higher than the OR of 1.33 (95% CI: 0.98–1.81, P = 0.064) for the Khorana score. The area under the curve for the Khorana score and D-dimer was 0.714, which was significantly higher than the 0.611 for the Khorana score alone, with the difference being significantly higher at 0.103 (P = 0.004, 95% CI: 0.033–0.173). Conclusions: The optimal D-dimer cutoff value for the diagnosis of DVT in patients with malignancy was 4.0 μg/mL. It was also suggested that the combination of the Khorana score with the D-dimer level was more accurate in diagnosing DVT than the Khorana score alone.

    DOI: 10.1016/j.avsg.2023.06.033

    Web of Science

    Scopus

    PubMed

  4. Factors Associated With Spontaneous Sac Shrinkage in Patients With Persistent Type 2 Endoleaks After EVAR

    Sugimoto, M; Banno, H; Sato, T; Ikeda, S; Tsuruoka, T; Kawai, Y; Niimi, K; Kodama, A; Komori, K

    JOURNAL OF ENDOVASCULAR THERAPY   30 巻 ( 4 ) 頁: 525 - 533   2023年8月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Endovascular Therapy  

    Purpose: Despite controversy surrounding the management of type 2 endoleaks (T2ELs) after endovascular aortic aneurysm repair (EVAR), the current European guidelines recommend reintervention for T2ELs when the aneurysm expands by ≥10 mm. Meanwhile, sac shrinkage ≥10 mm can be considered low risk for failure even with T2ELs, and the guidelines suggest less frequent follow-up delayed until 5 years after EVAR. This study reviewed patients with persistent T2ELs to identify predictors of spontaneous sac shrinkage (SpS) within 5 years. Methods: A retrospective review of elective EVAR for infrarenal aortic aneurysms between June 2007 and December 2017. Patients with >1 year follow-up and persistent T2ELs, defined as T2ELs confirmed at both the 6 and 12 month follow-up with contrast-enhanced computed tomography (CT), were included. Any reintervention or type 1 or 3 endoleaks within 12 months were excluded. SpS was defined as a ≥10 mm reduction in diameter without any reintervention. Aneurysm enlargement (AnE) was defined as a ≥5 mm increase in diameter. Factors associated with SpS within 5 years were analyzed. The clinical outcomes were reviewed. Results: Among 726 patients, 162 patients had persistent isolated T2ELs. After excluding 21 patients, 141 patients were enrolled. During a median follow-up of 43 months (interquartile range [IQR], 26–60), 28 SpS and 39 AnE were observed, and 31 reinterventions were performed. The cumulative rates of SpS were 14.2%±2.9% and 25.6%±5.1% at 1 and 5 years. Cox regression analysis revealed that the presence of ≥6 patent lumbar arteries had a significant negative correlation with SpS (p=0.036). During further follow-up after SpS, 2 reinterventions for type 1a and 3b endoleaks were required at 49 and 45 months. Conclusions: Patients with fewer patent lumbar arteries were likely to experience SpS within 5 years, even in the presence of persistent T2ELs. Follow-up imaging studies were advisable earlier than 5 years, even after SpS.

    DOI: 10.1177/15266028221083457

    Web of Science

    Scopus

    PubMed

  5. 胸部大動脈血管内治療と脊髄障害

    坂野 比呂志, 李 昌史, 池田 脩太, 川井 陽平, 杉本 昌之, 新美 清章

    脈管学   63 巻 ( 4 ) 頁: 45 - 49   2023年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本脈管学会  

    <p>われわれは以前より胸部大動脈瘤(TAA)に対するTEVAR後脊髄障害(SCI)は脆弱な壁在血栓による微小塞栓症である可能性を報告してきた。逆に壁在血栓の少ない大動脈解離(AD)に対するTEVARではSCI,塞栓症の発症が少ない傾向にあり,それを裏付ける結果の一つと言える。ADに対するTEVAR時SCI予防には側副血行,圧抜けなど脊髄への血流に留意する必要があると考えられる。</p>

    DOI: 10.7133/jca.23-00001

    CiNii Research

  6. The Association Between the D-dimer Level at 1 Year After EVAR and Sac Diameter Change in Patients With Persistent Type 2 Endoleak

    Sugimoto, M; Sato, T; Ikeda, S; Kawai, Y; Niimi, K; Banno, H

    JOURNAL OF ENDOVASCULAR THERAPY     頁: 15266028231170165   2023年4月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Endovascular Therapy  

    Purpose: Recent studies suggested that continuous clotting renewal in thrombi plays a central role in sac enlargement after endovascular aneurysm repair (EVAR). We reviewed patients with persistent type 2 endoleak (T2EL) to estimate the impact of D-dimer level on sac enlargement. Methods: A retrospective review of elective EVAR for infrarenal abdominal aortic aneurysm performed between June 2007 and February 2020. Persistent T2EL was defined as T2EL confirmed at both the 6 and 12 month contrast-enhanced computed tomography (CECT) follow-ups. “Isolated” T2EL was defined as T2EL without other types of endoleak within 12 months. Patients with >2 year follow-up, persistent isolated T2ELs, and D-dimer level data at 1 year (DD1Y) were included. Patients with any reintervention within 12 months were excluded. The association between DD1Y and aneurysm enlargement (AnE), defined as a ≥5 mm diameter increase, within 5 years was analyzed. Among 761 conventional EVAR, 515 patients had >2 years of follow-up. Thirty-three patients with any reintervention within 12 months and 127 patients without CECT at either 6 or 12 months were excluded. Among 131 patients with persistent isolated T2ELs, 74 patients with DD1Y data were enrolled. During a 37 month median follow-up [25–60, IQR], 24 AnEs were observed. In the AnE patients, the median DD1Y was significantly higher than that in the other patients (12.30 [6.88–21.90] vs 7.62 [4.41–13.00], P=0.024). ROC curve analysis indicated that the optimal cutoff point of DD1Y for AnE was 5.5 µg/mL (AUC=0.681). In univariate analysis, angulated neck, occlusion of the inferior mesenteric artery, and DD1Y≥5.5 µg/mL were significantly associated with AnE (P= 0.037, 0.038, and 0.010). Cox regression analysis revealed that DD1Y≥5.5 µg/mL was correlated with AnE (P=0.042, HR [95% CI] 4.520 [1.056–19.349]). Conclusion: A 1 year higher D-dimer level can potentially predict AnE within 5 years in persistent T2EL patients. AnE was considered improbable when the D-dimer level was low enough. Clinical Impact: The present study suggests that a 1-year higher D-dimer level could potentially predict aneurysm expansion within 5 years in patients with persistent type 2 endoleak (T2EL). On the other hand, aneurysm expansion was considered unlikely if the D-dimer level was low enough. As there are many patients with T2EL who require regular follow-up, any predictor of future aneurysm expansion could be of great help in conserving medical resources. In patients with a low likelihood of future expansion, we might consider delaying follow-up, similar to patients with sac shrinkage.

    DOI: 10.1177/15266028231170165

    Web of Science

    Scopus

    PubMed

  7. One-year sac regression is associated with freedom from fatal adverse events after endovascular aneurysm repair 査読有り

    Ikeda, S; Sato, T; Kawai, Y; Tsuruoka, T; Sugimoto, M; Niimi, K; Banno, H

    JOURNAL OF VASCULAR SURGERY   77 巻 ( 1 ) 頁: 136 - +   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Vascular Surgery  

    Objective: Although the predictors of long-term prognosis after endovascular aneurysm repair (EVAR) have been investigated, several reports have suggested that early sac shrinkage (ESS) is associated with superior long-term prognosis. However, it was not clear whether ESS was associated with aneurysm-related mortality. The aim of this study was to define fatal adverse events and to examine their association with ESS. Methods: All consecutive patients who underwent EVAR for an abdominal aortic aneurysm at Nagoya University Hospital between June 2007 and August 2018 were identified. We defined ESS as an aneurysm diameter decrease of 10 mm or more at 1 year after EVAR, and we defined fatal adverse events as aneurysm-related death, aneurysm sac rupture, open conversion, secondary type Ia endoleak, or secondary type IIIa/b endoleak. Then, we evaluated the association between ESS and fatal adverse events and identified predictors of ESS. Results: During the study period, 553 patients were identified and included. Fatal adverse events occurred in 42 patients (7.6%), and the details of the fatal adverse events were as follows: 13 aneurysm-related deaths, 17 aneurysm sac ruptures, 14 open conversions, 13 type Ia endoleaks, and 6 type III endoleaks. ESS occurred in 146 patients (26.4%). Kaplan-Meier curves showed that the ESS group had a significantly lower incidence of fatal adverse events (P <.001). Multivariate analysis showed that there were significant differences in terms of 5 or more preoperatively patent lumbar arteries (odds ratio [OR], 0.67; P =.049; 95% confidence interval [CI], 0.45-1.00), chronic kidney disease (OR, 0.49; P <.01; 95% CI, 0.29-0.84), and Zenith endograft use (OR, 1.76; P <.01; 95% CI, 1.16-2.67). Furthermore, the percentage of cases that achieved an aneurysm diameter of less than 40 mm was significantly higher in the ESS group (76.0% vs 15.5%; P <.01). The use of Zenith endografts showed a significantly higher rate of aneurysm disappearance than the use of Endurant endografts (P <.01) and Excluder endografts (P <.01). In addition, it was found that ESS was more likely to occur with the use of Zenith endografts, even when propensity score matching was performed for the neck morphology. Conclusions: ESS was associated with a lower rate of life-threatening adverse events after EVAR. The use of Zenith endografts was a predictor of ESS and was associated with increased rates of long-term sac shrinkage and aneurysm disappearance compared with the Endurant and Excluder endografts. Using the predictors of ESS identified in this study, we may be able to expand the indications for EVAR to patients with a longer life expectancy.

    DOI: 10.1016/j.jvs.2022.08.017

    Web of Science

    Scopus

    PubMed

  8. Severe Tortuosity of the Distal Descending Thoracic Aorta Affects the Accuracy of Distal Deployment During a Thoracic Endovascular Aortic Repair

    Sato, T; Banno, H; Ikeda, S; Kawai, Y; Tsuruoka, T; Sugimoto, M; Niimi, K; Kodama, A; Komori, K

    JOURNAL OF ENDOVASCULAR THERAPY     頁: 15266028221141023   2022年12月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Endovascular Therapy  

    Purpose: An accurate distal deployment is essential for successful thoracic endovascular aortic repair (TEVAR) of a paradiaphragmatic aortic aneurysm. This study aimed to investigate the anatomical and intraoperative factors that affect the accuracy of distal deployment during TEVAR. Methods: We conducted a retrospective review of preoperative and postoperative computed tomography scans of 426 patients undergoing TEVAR at our institution between October 2008 and May 2021, of which the stent-graft was attempted to be deployed just above the celiac axis or the superior mesenteric artery in 56 patients. Based on the anatomical factors related to the malposition (deployed >10 mm away from the target vessel) and the greater curve to the straight-line ratio (G/S ratio), the patients were categorized as severe tortuosity (n=21) and mild tortuosity (n=35) groups to compare the operative and clinical outcomes. Result: Stent-graft malpositioning occurred in 21 cases. Among all anatomical variables, only the G/S ratio was significantly larger in the malpositioned cases (p=0.049). A cutoff G/S ratio value of 1.15 was determined using the receiver operating curve analysis. In the severe tortuosity group, the distal end of the stent-graft was significantly farther (median: 10.0 [interquartile range (IQR): 2.5–19.5] mm vs 3.0 [0–8.0] mm; p=0.015) from the target vessel, and the tilt angle of the stent-graft’s distal edge was larger (median: 21.4 [IQR: 15.8–24.5] vs 9.5 [5.5–12.5] degree; p<0.01) than that in the mild tortuosity group. Both groups were comparable for the incidence of a primary type Ib endoleak (p=0.454), a secondary type Ib endoleak (p=1.0), and the rate of distal reintervention (p=0.276). Conclusion: Severe tortuosity in the distal descending thoracic aorta is associated with a malpositioned and tilted distal end of the stent-graft. Clinical Impact: Thoracic endovascular aortic repair (TEVAR) for paradiaphragmatic thoracic aortic aneurysms requires accurate distal landing. In this paper, a retrospective CT analysis revealed that the greater curve to the straight-line ratio (G/S ratio) was associated to affects the malposition of the stent graft, defined as being deployed more than 10 mm away from the target vessel. Further, a comparative analysis based on the G/S ratio demonstrated that severe aortic tortuosity was associated with a more distal and tilted deployment of the stent graft.

    DOI: 10.1177/15266028221141023

    Web of Science

    Scopus

    PubMed

  9. Epicardial adipose tissue volume is associated with abdominal aortic aneurysm expansion

    Kawai, Y; Banno, H; Sato, T; Ikeda, S; Tsuruoka, T; Sugimoto, M; Niimi, K; Kodama, A; Matsui, K; Matsui, S; Komori, K

    JOURNAL OF VASCULAR SURGERY   76 巻 ( 5 ) 頁: 1253 - 1260   2022年11月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Vascular Surgery  

    Background: The epicardial adipose tissue volume (EATV) is associated with cardiovascular diseases such as coronary artery disease. However, no information is available regarding the relationship between the EATV and abdominal aortic aneurysm (AAA) expansion. In the present study, we evaluated the association between the EATV and AAA growth and sought to identify the predictors of AAA expansion. Methods: Between June 2009 and December 2019, 906 patients had undergone endovascular or open repair of AAAs at our institution. Patients with previous cardiac surgery, previous ascending thoracic aortic surgery, a ruptured AAA, an infected AAA, an inflammatory AAA, a saccular aneurysm, a solitary iliac aneurysm, or reintervention after treatment of the AAA were excluded. A total of 237 patients with at least two preoperative computed tomography (CT) scans performed >180 days apart were included in the present study. The EATV within the pericardium was retrospectively quantified from the preoperative non–contrast-enhanced CT images using a three-dimensional workstation. The EATV index was defined as the EATV divided by the body surface area. The AAA expansion rate was defined as an increase in the AAA diameter annually, and the patients were divided into the slow-expansion group (expansion rate, <5 mm/y) and the fast-expansion group (expansion rate, ≥5 mm/y). The correlation between the expansion rate and the EATV index was analyzed, and the cutoff value for the EATV index was determined using a receiver operating characteristics curve. Multivariate analysis was used to assess the predictors of the AAA expansion rate. Results: The expansion rate of AAA correlated positively with the EATV index (R = 0.237; P < .001). The initial aneurysm diameter (P < .001) and EATV index (P = .009) differed significantly between the two groups. The cutoff for the EATV index was 60.3 cm3/m2 (area under the curve, 0.658; 95% confidence interval [CI], 0.568–0.749; sensitivity, 1.000; specificity, 0.309). Multivariate analysis revealed that the initial aneurysm diameter and an EATV index of >60.3 cm3/m2 were significantly associated with the AAA expansion rate. Conclusions: The results of the present study have demonstrated that the EATV index is associated with AAA expansion.

    DOI: 10.1016/j.jvs.2022.04.032

    Web of Science

    Scopus

    PubMed

  10. Impact of Serum Zinc Level and Oral Zinc Supplementation on Clinical Outcomes in Patients Undergoing Infrainguinal Bypass for Chronic Limb-Threatening Ischemia

    Kodama, A; Komori, K; Koyama, A; Sato, T; Ikeda, S; Tsuruoka, T; Kawai, Y; Niimi, K; Sugimoto, M; Banno, H; Nishida, K

    CIRCULATION JOURNAL   86 巻 ( 6 ) 頁: 995 - 1006   2022年5月

     詳細を見る

    記述言語:英語   出版者・発行元:一般社団法人 日本循環器学会  

    Background: Zinc (Zn) has been reported to play an important role in wound healing (WH). Nevertheless, the effect of Zn in chronic limb-threatening ischemia (CLTI) patients is unclear. This study investigated the effect of Zn on the clinical outcomes of CLTI patients undergoing bypass surgery. Methods and Results: This study reviewed 111 consecutive patients who underwent an infrainguinal bypass from 2012 to 2020. Patients with Zn deficiency (serum Zn level <60 μg/dL) received oral Zn supplementation and maintained a normal level until WH. This study aimed to explore: (1) the effect of Zn deficiency; and (2) Zn supplementation in Zn-deficient patients on the clinical outcomes of this cohort. Patients with Zn deficiency, Zn supplementation, and no Zn supplementation despite Zn deficiency accounted for 48, 21, and 42 patients, respectively. (1) Zn deficiency was associated with WH (HR, 0.47; 95% CI, 0.29-0.78: P=0.003), major adverse limb events (MALE) (HR, 2.53; 95% CI, 1.26-5.09: P=0.009), and major amputation or death (HR, 3.17; 95% CI, 1.51-6.63: P=0.002). (2) Zn supplementation was positively related to WH (HR, 2.30; 95% CI, 1.21-4.34: P=0.011). This result was confirmed using propensity score matching (HR, 2.24; 95% CI, 1.02-4.87: P=0.043). Conclusions: The current study revealed that Zn level was associated with clinical outcomes in CLTI patients after bypass surgery. Oral Zn supplementation could improve WH in these patients.

    DOI: 10.1253/circj.cj-21-0832

    Web of Science

    Scopus

    PubMed

    CiNii Research

  11. New Morphological Factor for Predicting Late Proximal Type I Endoleak after Endovascular Aneurysm Repair

    Banno, H; Sugimoto, M; Sato, T; Ikeda, S; Kawai, Y; Tsuruoka, T; Kodama, A; Komori, K

    ANNALS OF VASCULAR SURGERY   81 巻   頁: 154 - 162   2022年4月

     詳細を見る

    記述言語:英語   出版者・発行元:Annals of Vascular Surgery  

    Background: Although we have witnessed several cases of late proximal type I endoleak (T1AEL) after endovascular aneurysm repair (EVAR), most patients did not have “hostile neck” preoperatively. We hypothesized that the distance between the lowest renal artery and the neck angulation point and neck length are the 2 most important factors for maintaining long-term proximal sealing. This study evaluated “neck hostility,” which is the product of the distance to the angulation point and the neck length, as a preoperative morphological risk factor for the development of late T1AEL after EVAR. Methods: A retrospective review of a prospectively assembled database was performed for all patients who had undergone EVAR at a single institution from June 2007 to May 2017. Patient demographics and preoperative imaging data were collected, and Cox regression analysis was performed to identify the risk factors for late T1AEL. Results: Of the 655 patients who underwent EVAR during the study period, 115 were excluded due to complex EVAR (n = 14), primary indications for iliac aneurysms (n = 86), primary T1AEL (n = 3), or other reasons (n = 15). Of the remaining 537 patients, twelve patients (2.2%) developed late T1AEL a median of 3.2 (interquartile range [IQR]; 3.0, 5.4) years after EVAR. Receiver operating characteristic (ROC) curve analysis revealed a neck hostility cutoff value of 8. Cox regression analysis revealed that a neck hostility value ≤8 and conical neck anatomy were risk factors for the development of late T1AEL after EVAR. Well-known hostile neck factors such as short neck, severe angulated neck, and severe calcification/thrombus in the proximal neck were not significantly different. Conclusions: The present study demonstrated a correlation between late T1AEL and the product of the angulation distance and the neck length. This factor may be useful for predicting poor late proximal outcomes after EVAR.

    DOI: 10.1016/j.avsg.2021.09.049

    Web of Science

    Scopus

    PubMed

  12. Preoperative sarcopenia and malnutrition are correlated with poor long-term survival after endovascular abdominal aortic aneurysm repair 査読有り

    Ikeda, S; Kodama, A; Kawai, Y; Tsuruoka, T; Sugimoto, M; Niimi, K; Banno, H; Komori, K

    SURGERY TODAY   52 巻 ( 1 ) 頁: 98 - 105   2022年1月

     詳細を見る

    記述言語:英語   掲載種別:学位論文(博士)   出版者・発行元:Surgery Today  

    Purpose: Sarcopenia and malnutrition are often used as surrogates for frailty, which is predictive of poor prognosis after surgery. We investigated the effects of sarcopenia and malnutrition on mortality after endovascular aneurysm repair (EVAR). Methods: The subjects of this study were patients who underwent EVAR at our hospital between June 2007 and December 2013, excluding those who underwent reintervention. The psoas muscle area at the L4 level was used as an indicator of sarcopenia. The Geriatric Nutritional Risk Index was used as an indicator of malnutrition. Results: There were 324 patients included in the study, with a mean age of 78.1 years and a median follow-up period of 56.7 months. Multivariate analysis revealed that sarcopenia (HR, 1.79; p =.042) and malnutrition (HR, 1.78; p =.043) were independent prognostic factors. Patients with both factors were classified as the high-risk group and others were classified as the low-risk group. The survival rate was significantly lower in the high-risk group than in the low-risk groups (p <.001). Even after propensity score matching, the high-risk group had a significantly lower survival rate (p <.001). Conclusion: Both sarcopenia and malnutrition were associated with long-term mortality after EVAR. Patients with both indicators had a poor mid-term survival.

    DOI: 10.1007/s00595-021-02362-x

    Web of Science

    Scopus

    PubMed

▼全件表示

講演・口頭発表等 11

  1. Femoral Vein Transposition の1例

    池田脩太、大澤拓哉、李 昌史、川井陽平、杉本昌之、新美清章、坂野比呂志

    第1回東海静脈学会地方会学術集会  2024年2月17日 

     詳細を見る

    開催年月日: 2024年2月

    記述言語:日本語   会議種別:口頭発表(一般)  

  2. ALTO留置中にPigtail カテーテルによりミッドクラウンが変形した症例

    池田脩太、李昌史、川井陽平、杉本昌之、新美清章、坂野比呂志

    第26回大動脈ステントグラフト研究会  2023年11月3日 

     詳細を見る

    開催年月日: 2023年11月

    記述言語:日本語  

  3. EVAR後瘤径拡大とIMA塞栓術及び腰動脈開存の関連についての検討

    池田脩太、李昌史、川井陽平、杉本昌之、新美清章、坂野比呂志

    第64回日本脈管学会学術総会  2023年10月26日 

     詳細を見る

    開催年月日: 2023年10月

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(公募)  

  4. Outcome of open conversion after EVAR

    Shuta Ikeda, Changi Lii, Yohei Kawai, Masayuki Sugimoto, Kiyoaki Niimi, Hiroshi Banno

    2023年3月24日 

     詳細を見る

    開催年月日: 2023年3月

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(指名)  

  5. Excluder conformable初期使用経験 招待有り

    2023年3月11日 

     詳細を見る

    開催年月日: 2023年3月

    記述言語:日本語   会議種別:口頭発表(招待・特別)  

  6. AAA治療とコイル塞栓術 招待有り

    池田脩太

    2023年3月8日 

     詳細を見る

    開催年月日: 2023年3月

    記述言語:日本語   会議種別:口頭発表(招待・特別)  

    国名:日本国  

  7. 新デバイスALTO 招待有り

    池田脩太、李昌史、川井陽平、杉本昌之、新美清章、坂野比呂志

    池田脩太、李昌史、川井陽平、杉本昌之、新美清章、坂野比呂志  2022年12月3日 

     詳細を見る

    開催年月日: 2022年12月

    記述言語:日本語   会議種別:口頭発表(招待・特別)  

  8. 早期瘤縮小とEVAR後致命的合併症 招待有り

    池田脩太

    2022年9月10日 

     詳細を見る

    開催年月日: 2022年9月

    記述言語:日本語   会議種別:口頭発表(招待・特別)  

  9. Cook Zenith endograft and early sac shrinkage, which is associated with fewer serious complications after endovascular aneurysm repair

    Shuta Ikeda, Tomohiro Sato, Yohei Kawai, Takuya Tsuruoka, Masayuki Sugimoto, Kiyoaki Niimi, Hiroshi Banno.  2022年6月10日 

     詳細を見る

    開催年月日: 2022年6月

    記述言語:英語   会議種別:口頭発表(一般)  

  10. Impact of type 2 endoleak after TEVAR

    Shuta Ikeda, Tomohiro Sato, Yohei Kawai, Takuya Tsuruoka, Masayuki Sugimoto, Kiyoaki Niimi, Akio Kodama, Hiroshi Banno, Kimihiro Komori

    2022年5月26日 

     詳細を見る

    開催年月日: 2022年5月

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(公募)  

    国名:日本国  

  11. コロナ禍における右浅大腿動脈瘤破裂の1例

    池田脩太,佐藤誠洋, 川井陽平,鶴岡琢也, 杉本昌之,新美清章,児玉章朗,坂野比呂志,古森公浩

    血管外科学会東海北陸地方会  2022年3月12日 

     詳細を見る

    開催年月日: 2022年3月

    記述言語:日本語   会議種別:口頭発表(一般)  

▼全件表示